What happens after an overdose of a GLP-1 agonist such as semaglutide? This appraisal examines US poison-centre data on dosing errors, reported symptoms and hypoglycaemia, and considers how incomplete reporting and broad outcome definitions limit what the study can tell emergency clinicians.